XS
MDGL icon

XR Securities’s Madrigal Pharmaceuticals MDGL Stock Holding History

XR Securities’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,400
Closed -$641K – 290
2024
Q1 		$641K Hold
2,400
– – 0.02% 180
2023
Q4 		$555K Buy
+2,400
New +$420K 0.02% 251
2023
Q3 		– Sell
-1,500
Closed -$347K – 414
2023
Q2 		$347K Buy
+1,500
New +$406K 0.02% 275
2023
Q1 		– Sell
-16,200
Closed -$4.7M – 503
2022
Q4 		$4.7M Buy
+16,200
New +$1.58M 0.46% 36

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return